Figure 2. Dose curve of treatment with recombinant eNOS on NOS activity. Quiescent REC were treated with different doses of recombinant eNOS under high glucose conditions and analyzed by ELISA for NOS activity. *p<0.05 versus HG control. n=3. Data are mean ± SEM.